Danaher | DHR - Gross Profit On Sales

Stock Price
174.63
Daily Change
0.59 0.34%
Monthly
-9.10%
Yearly
-8.11%
Q2 Forecast
171.51

Danaher reported $3.59B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Abbott USD 5.86B 675M Mar/2026
Agilent USD 946M 44M Dec/2025
Align Technology USD 736.59M 53M Mar/2026
Becton, Dickinson and Co. USD 2.41B 1.72B Dec/2025
Bio Techne USD 191.28M 3.16M Dec/2025
Bio-Rad Laboratories USD 345.2M 1.8M Dec/2025
Boston Scientific USD 3.61B 64M Mar/2026
Bruker USD 449.2M 69.8M Dec/2025
Charles River Laboratories USD 271.96M 39.43M Dec/2025
Danaher USD 3.59B 375M Mar/2026
Dentsply International USD 443M 2M Dec/2025
Edwards Lifesciences USD 1.29B 59.4M Mar/2026
ESCO Technologies USD 99.6M 49.54M Dec/2025
Fortive USD 675.5M 33.4M Mar/2026
Henry Schein USD 1.07B 7M Mar/2026
Illumina USD 721M 38M Mar/2026
Intuitive Surgical USD 1.83B 73.8M Mar/2026
IQVIA Holdings USD 1.12B 32M Dec/2025
Keysight Technologies USD 995M 126M Dec/2025
Laboratory Of America USD 1.01B 20.6M Mar/2026
Medtronic USD 5.41B 27M Dec/2025
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Myriad Genetics USD 146.8M 3M Dec/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Quest Diagnostics USD 906M 33M Mar/2026
Quidel USD 274.8M 1.01B Dec/2025
Repligen USD 103.83M 3.32M Dec/2025
Revvity USD 387.66M 34M Mar/2026
Roper Industries USD 1.43B 26.9M Dec/2025
Stryker USD 3.81B 675M Mar/2026
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Waters USD 557.42M 97.44M Dec/2025
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025